Conference Programme
New Horizons for Bio Innovation
4 July 2024
Our Programme
Keynote Presentations & Panel Discussions
Enjoy a day of Keynote Presentations and Panel discussions, plus the Exhibition Area and networking opportunities.
In the dynamic landscape of improving patient outcomes, New Horizons refers to the advances in diagnostics, technology, therapeutics and ecosystems that are enabling future innovation in patient treatments.
Registration
Welcome
Jon Green, One Nucleus
New Horizons for Therapeutic Modalities
Our opening session New Horizons for Therapeutic Modalities will explore advances in emerging fields such as gene therapies and RNA therapeutics while also addressing the associated challenges from regulatory to biological and chemical considerations to support the future of these treatment modalities.
- Keynote presentation: Kia Pedersen, COO, Pelago Bioscience
- Pitches from two exciting companies to watch
- Panel discussion
Moderator: Hugh Nuthall, Eli Lilly
Panellists: Benjamin Taylor, AstraZeneca
Morning Coffee and Networking Break
New Horizons for Biomarker Technologies
Biomarkers are a very valuable tool in translational research offering significant opportunity for advances in diagnostics, therapeutics and personalised healthcare. Our session will explore biomarker applications and complexities associated with inventions in this field including:
- Keynote presentation
Chris Hodkinson, Owlstone Medical - Pitches from two exciting companies to watch:
Mark Eccleston, Volition, Jenny Barnett, Monument Therapeutics - Panel discussion
Moderator: Edward Rainsford, Appleyard Lees
Panellists: Yue Xuan, Thermo Fisher Scientific, Mark Eccleston, Volition, Jenny Barnett, Monument Therapeutics
Lunch and Networking
TechBio – Is it Truly Simplifying Complexity?
TechBio is impacting the drug discovery and development process in different ways. Along with a showcase of companies leveraging cutting edge data-driven techniques, our session will tackle the question of whether the outcomes are indeed better featuring:
- Keynote presentation – Collaborative Drug Discovery
- Pitches from two exciting companies to watch
- Panel discussion
Moderator: Rowan Gardner, PrecisionLife
Afternoon Coffee and Networking Break
Translational Research in a Global Village
The closing session will reflect on the political and institutional relationships driving the UK life science sector’s growth as a global bioinnovation location featuring:
- Panel discussion on Learning from Boston Bootcamp
Moderator: Ross McNaughton, Taylor Wessing
Panellists: Katie Binley, Ikarovec, Matthew Fyfe, Storm Therapeutics, Mike Davies, Carocell Bio, Hazel Jones, Enhanc3D Genomics - Keynote presentation
- Panel discussion on Connecting Global Innovation
Closing Remarks
Tony Jones, One Nucleus
Networking Drinks Reception
End
Programme is subject to change